标题
Safety of Japanese encephalitis vaccines
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 17, Issue 11, Pages 4259-4264
出版商
Informa UK Limited
发表日期
2021-10-09
DOI
10.1080/21645515.2021.1969852
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV®) in Taiwan, 2017–18
- (2020) Hsuan-Yin Ma et al. VACCINE
- Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019
- (2020) Hee Soo Kim et al. Infectious Diseases and Therapy
- Review of Emerging Japanese Encephalitis Virus: New Aspects and Concepts about Entry into the Brain and Inter-Cellular Spreading
- (2019) Filgueira et al. Pathogens
- Mortality and Disability Due to Japanese Encephalitis in Elderly Adults: Evidence From an Adult Tertiary Care Center in West China
- (2019) Weixi Xiong et al. Frontiers in Neurology
- Recommendations for the use of Japanese encephalitis vaccines
- (2019) Ping-Ing Lee et al. Pediatrics and Neonatology
- Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study
- (2018) Thiem Dinh Vu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Systematic review of seroepidemiological studies on Japanese encephalitis in the Republic of Korea
- (2018) Young June Choe et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012–2016
- (2018) William L. Walker et al. VACCINE
- Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine
- (2018) Ki Wook Yun et al. VACCINE
- Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
- (2018) Pornthep Chanthavanich et al. Human Vaccines & Immunotherapeutics
- Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand
- (2017) Tawee Chotpitayasunondh et al. VACCINE
- Japanese encephalitis virus infection, diagnosis and control in domestic animals
- (2017) Karen L. Mansfield et al. VETERINARY MICROBIOLOGY
- Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies
- (2017) Amy Sarah Ginsburg et al. Human Vaccines & Immunotherapeutics
- Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
- (2017) Shyam Raj Upreti et al. PLoS Neglected Tropical Diseases
- Retrospective Analysis of Posaconazole Suspension Dosing Strategies in a Pediatric Oncology Population: Single-Center Experience
- (2017) Sherry Mathew et al. Journal of the Pediatric Infectious Diseases Society
- Epidemiological Features of Japanese Encephalitis in Taiwan from 2000 to 2014
- (2016) Yu-Kang Chang et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
- (2016) SirajAhmed Khan et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea
- (2016) Dong Soo Kim et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
- (2016) Pushpa Ranjan Wijesinghe et al. VACCINE
- Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis
- (2015) Shi-Yuan Wang et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review
- (2015) Xing Li et al. Human Vaccines & Immunotherapeutics
- Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2
- (2014) Emmanuel Feroldi et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012
- (2014) Yu Liu et al. VACCINE
- Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China
- (2014) Yali Wang et al. VACCINE
- A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
- (2014) Dong Soo Kim et al. Human Vaccines & Immunotherapeutics
- The Incidence of Japanese Encephalitis in Taiwan—A Population-Based Study
- (2014) Li-Ching Hsu et al. PLoS Neglected Tropical Diseases
- Vaccine Strategies for the Control and Prevention of Japanese Encephalitis in Mainland China, 1951–2011
- (2014) Xiaoyan Gao et al. PLoS Neglected Tropical Diseases
- Estimation of the Impact of a Japanese Encephalitis Immunization Program with Live, Attenuated SA 14-14-2 Vaccine in Nepal
- (2013) Shyam Raj Upreti et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children
- (2013) Emmanuel Feroldi et al. Human Vaccines & Immunotherapeutics
- Japanese encephalitis
- (2013) Sang-Im Yun et al. Human Vaccines & Immunotherapeutics
- Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
- (2012) Elina O. Erra et al. CLINICAL INFECTIOUS DISEASES
- Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV)
- (2012) Mohan Babu Appaiahgari et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Epidemiology of Japanese encephalitis in South Korea, 2007–2010
- (2012) Dong-Woo Lee et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Japanese encephalitis and Japanese encephalitis virus in mainland China
- (2012) Yayun Zheng et al. REVIEWS IN MEDICAL VIROLOGY
- Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial
- (2012) Emmanuel Feroldi et al. Human Vaccines & Immunotherapeutics
- Estimated global incidence of Japanese encephalitis:
- (2011) Grant Campbell et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- New Japanese encephalitis vaccines: alternatives to production in mouse brain
- (2011) Scott B Halstead et al. Expert Review of Vaccines
- Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia
- (2011) X.-L. Pan et al. JOURNAL OF VIROLOGY
- Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds
- (2010) Kulkanya Chokephaibulkit et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Adverse event reports following Japanese encephalitis vaccination in the United States, 1999–2009
- (2010) Nicole P. Lindsey et al. VACCINE
- Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
- (2010) Joseph Torresi et al. VACCINE
- Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
- (2010) Yongxin Yu VACCINE
- Ixiaro®: a new vaccine against Japanese encephalitis
- (2009) Tomas Jelinek Expert Review of Vaccines
- An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis
- (2009) N. M. Dung et al. JOURNAL OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More